FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/063156 [Registered on: 26/02/2024] Trial Registered Prospectively
Last Modified On: 17/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effectiveness of Silk fibroin powder dressing in Superficial surgical site infections(SSI) in abdomen surgeries when compared to Saline dressings in wound healing. 
Scientific Title of Study   Effectiveness of Silk fibroin powder dressing in Superficial surgical site infections(SSI) in post laparotomy wounds when compared to Saline dressings in wound healing. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Chandavaram Bhanu Prakash 
Designation  Junior Resident 
Affiliation  JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH 
Address  Surgery department, 2nd floor,old block, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Dhanvantri nagar, Puducherry-605006 India

Pondicherry
PONDICHERRY
605006
India 
Phone  7207693553  
Fax    
Email  bhanucprakash1@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Uday Shamrao Kumbhar 
Designation  professor 
Affiliation  JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH 
Address  Surgery department, 2nd floor,old block, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Dhanvantri nagar, Puducherry-605006 India

Pondicherry
PONDICHERRY
605006
India 
Phone  9940306508  
Fax    
Email  K26uday74@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Uday Shamrao Kumbhar 
Designation  professor 
Affiliation  JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH 
Address  Surgery department, 2nd floor, old block, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Dhanvantri Nagar, Puducherry-605006 India

Pondicherry
PONDICHERRY
605006
India 
Phone  9940306508  
Fax    
Email  K26uday74@yahoo.co.in  
 
Source of Monetary or Material Support  
Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) hospital and institue 
 
Primary Sponsor  
Name  Jawaharlal Institute of Postgraduate Medical Education Research JIPMER 
Address  Surgery Department, 2nd floor, old block, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Dhanvantri nagar, Puducherry-605006 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr CHANDAVARAM BHANU PRAKASH  JIPMER HOSPITAL, JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH  SURGERY DEPARTMENT, 2 nd floor , old block,JIPMER, DHANVANTARI NAGAR , PUDUCHERRY-60500 6 Pondicherry PONDICHERRY
Pondicherry
PONDICHERRY 
7207693553

bhanucprakash1@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Jipmer Institutional Ethics Committe Interventional studies  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L768||Other intraoperative and postprocedural complications of skin and subcutaneous tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Application of silk fibroin powder on surgical site infections in post laparotomy patients  Application of silk fibroin powder on surgical site infections in post laparotomy patients and assess wound on 5 th , 10 th and 15 th day 
Comparator Agent  normal saline dressing in superficial surgical site infections in post laparotomy patients  Application of normal saline dressing in superficial ssi in post laparotomy patients and asssessing wound on 5 th ,10 and 15 th day 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Consenting post midline laparotomy patients with age more than 18
yrs having superficial SSI with wound dehiscence 
 
ExclusionCriteria 
Details  1.supericial ssi with wound dehiscence of more than 2 weeks
duration.
2.surgeries involving implants eg: mesh in incisional hernias.
3.patients receiving chemotherapy ,radiotherapy, immunotherapy ,or
completed therapy with in last one month.
4.Hemodynamically un stable patients.
5.patients in sepsis.
6.patients with re-laparotomies.
7.patients who are allergic to silk products
8.patients who are included in other trials. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
wound healing time measured by dr. kamal
adaptive wound healing score 
wound healing time measured by dr. kamal
adaptive wound healing score 
 
Secondary Outcome  
Outcome  TimePoints 
1.amount of wound exudate by weighing soaked
gauze pieces using digital scale.
2. length of hospital stay measured in days.
3.Scar characteristics assessed by vancouver
scar scale 
3 months 
 
Target Sample Size   Total Sample Size="142"
Sample Size from India="142" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   27/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [bhanucprakash1@gmail.com].

  6. For how long will this data be available start date provided 24-02-2024 and end date provided 27-02-2026?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  
EFFECTIVENESS OF SILK FIBROIN DRESSING IN POST LAPAROTOMY PATIENTS SUPERFICIAL SURGICAL SITE INFECTIONS COMPARED TO SALINE
DRESSING IN WOUND HEALING.

PRIMARY PURPOSE : To compare the effectiveness of silk fibroin dressing and normal saline
dressing in wound healing time measured by kamal’s adaptive wound healing score.
BRIEF STUDY HYPOTHESIS :
SSI is defined as the infection that occurs within 30 days of operative procedure
or within a year of implant placement if implant is placed and the infection is
thought to be secondary to surgery. Negative pressure dressing is a new
technique in treating ssi.
Likewise silk fibroin is also emerging methods of treating SSI, proven in some
studies as an effective method to reduce wound healing time and complications
that arise due to SSI. Silk-based biomaterials stand out for its versatility and
natural biocompatibility. They are available as many formats i.e., mats,
sheets,foam,gel, powder. Silk biomaterials have been applied, e.g., in bone,
cartilage, muscular tissue.
Control of the biodegradation rate of the silk hydrogel and its high bioactivity
makes this biomaterial a choice for soft tissue engineering in comparison to other
hydrogel-based formulations, such as polydimethylsiloxane (PDMS) and
agarose(8), that show a negligible degradation due to the lack, in mammalian
tissues, of enzymes able to decompose such materials .
A randomized clinical trial proved that applying silk fibroin decreases both wound
healing time and adverse effects compared to other commercial dressings.
i.e.,100 % healed by 14 days,and 88.6 % with controlled wound dressing
improved in 19 days.
In this study I would like to test efficacy of silk fibroin in regeneration of soft tissue
and wound healing in SSI developed in laparotomy patients
 
Close